Where this storyline stands
A study led by investigators at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) suggests that intensive cardiac surveillance programs routinely used for lymphoma patients with low to moderate cardiovascular risk who are treated with anthracyclines may have limited clinical value.
Complete chronological journey
Every chapter below is ordered by its exact event time, from the earliest connected report to the newest development.
- 01How it started01 — How it started
Study questions the value of intensive cardiac surveillance in cancer patients treated with anthracyclines
What happened
A study led by investigators at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) suggests that intensive cardiac surveillance programs routinely used for lymphoma patients with low to moderate cardiovascular risk who are treated with a Study questions the value of intensive cardiac surveillance in cancer patients treated with anthracyclines
Why it matters
The development may affect how technology is built, regulated or used. The practical impact depends on technical details, availability and independent evaluation.